GAABRYDA Trademark

Trademark Overview

On Friday, October 2, 2020, a trademark application was filed for GAABRYDA with the United States Patent and Trademark Office. The USPTO has given the GAABRYDA trademark a serial number of 90232607. The federal status of this trademark filing is REGISTERED as of Tuesday, November 28, 2023. This trademark is owned by Marinus Pharmaceuticals, Inc.. The GAABRYDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, encephalopathies, neurodegenerative disease, cerebrovascular disease, movement disorders, traumatic brain injury and other neurologic conditions, substance abuse, substance withdrawal, dementia, delirium, schizophrenia, bipolar disorder, psychosis, depression, and other psychiatric conditions
gaabryda

General Information

Serial Number90232607
Word MarkGAABRYDA
Filing DateFriday, October 2, 2020
Status700 - REGISTERED
Status DateTuesday, November 28, 2023
Registration Number7231187
Registration DateTuesday, November 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, encephalopathies, neurodegenerative disease, cerebrovascular disease, movement disorders, traumatic brain injury and other neurologic conditions, substance abuse, substance withdrawal, dementia, delirium, schizophrenia, bipolar disorder, psychosis, depression, and other psychiatric conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 17, 2020
Primary Code005
First Use Anywhere DateFriday, September 15, 2023
First Use In Commerce DateFriday, September 15, 2023

Trademark Owner History

Party NameMarinus Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRadnor, PA 19087
Party NameMarinus Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRadnor, PA 19087
Party NameMarinus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRadnor, PA 19087

Trademark Events

Event DateEvent Description
Tuesday, November 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 28, 2023REGISTERED-PRINCIPAL REGISTER
Friday, October 27, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 26, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 12, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 28, 2023USE AMENDMENT FILED
Tuesday, October 10, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 28, 2023TEAS STATEMENT OF USE RECEIVED
Friday, June 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 31, 2023SOU EXTENSION 4 GRANTED
Wednesday, May 31, 2023SOU EXTENSION 4 FILED
Wednesday, May 31, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2022SOU EXTENSION 3 GRANTED
Tuesday, November 8, 2022SOU EXTENSION 3 FILED
Tuesday, November 8, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 28, 2022SOU EXTENSION 2 GRANTED
Monday, March 28, 2022SOU EXTENSION 2 FILED
Monday, March 28, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 3, 2021SOU EXTENSION 1 GRANTED
Friday, December 3, 2021SOU EXTENSION 1 FILED
Friday, December 3, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 8, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 27, 2021ASSIGNED TO EXAMINER
Tuesday, November 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 6, 2020NEW APPLICATION ENTERED

Related Keywords

gaabryda other disease substance conditions neurologic withdrawal abuse dementia delirium depression